Omalizumab and allergen immunotherapy in a patient with asthma and inhaled corticosteroid-induced adrenal suppression.
National Capital Consortium Pediatrics Residency, Walter Reed National Military Medical Center, Bethesda, Maryland. Electronic address: Jason.T.Forbush2.mil@mail.mil.
Jason T
JT
Forbush
Allergy, Immunology, and Immunization Service, Walter Reed National Military Medical Center, Bethesda, Maryland.
Taylor A
TA
Banks
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D000485:Allergens / Q000276:immunology*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology* / Q000378:metabolism; D002648:Child; D003888:Desensitization, Immunologic / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D000069444:Omalizumab / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000485:Allergens; D018927:Anti-Asthmatic Agents; D000069444:Omalizumab